Arkangel AI: Outsmarting Gastric Cancer with Predictive AI Breakthroughs

Gastric cancer, also known as stomach cancer, persists as one of the main culprits of cancer-related mortality worldwide. Recognition often occurs in the later stages because early symptoms are confusing, along with the challenges inherent in identifying precancerous lesions using conventional diagnostic approaches. The pervasiveness of this serious health problem was evident in 2020, with an estimated incidence of 1,089,103 new cases along with 768,793 deaths attributable to gastric cancer (1)(2). Adding to this concern is the remarkably high incidence of precancerous conditions in people with known risk factors, requiring the development and implementation of more effective and generally accessible diagnostic techniques (3)(4).

• Gastric cancer is often recognized in later stages due to confusing early symptoms and challenges in identifying precancerous lesions.
• In 2020, there were an estimated 1,089,103 new cases and 768,793 deaths from gastric cancer.
• There is a high incidence of precancerous conditions in people with known risk factors, necessitating better diagnostic techniques.

GastricHealthAI, tool to help doctors by providing real-time advice for gastric cancer based on current research and clinical guidelines.

GastricHealthAI uses a clinical guideline from the National Comprehensive Cancer Network (NCCN) (5). This guideline provide evidence-based recommendations that inform the attendee's risk assessments and diagnostic suggestions.